H.R. 10038House118th Congress (2023-2025)In Committee

To direct the Secretary of Veterans Affairs to conduct a pilot program on the provision of naloxone to veterans and their caregivers, and for other purposes.

AI-Generated Summary

Updated January 20, 2026 at 7:48 PM UTC

The bill directs the Secretary of Veterans Affairs to run a two‑year pilot program that provides free naloxone, an opioid‑overdose reversal medication, to veterans and their registered caregivers at VA pharmacies and medical facilities without a prescription. It also requires the VA to give recipients information about addiction, suicide prevention, mental‑health services, and how to use naloxone, and to report the program’s results to Congress.

Key Provisions

VA will make naloxone available at no charge to any veteran or registered caregiver, without a prescription, for a two‑year pilot period.
Recipients must receive information about addiction services, suicide prevention, mental‑health services, and education on naloxone use.
Within 90 days after the pilot ends, the Secretary must submit a report to Congress detailing the number of recipients, feasibility of expanding to veterans’ immediate family and non‑VA providers, impact of a second‑time consultation requirement, budget considerations, and any recommendations.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions

HouseCommittee Latest Action

Referred to the Subcommittee on Health.

Health Subcommittee

November 8, 2024

View full timeline

HouseIntro Referral

Introduced in House

October 25, 2024

HouseIntro Referral

Referred to the House Committee on Veterans' Affairs.

Veterans' Affairs Committee

October 25, 2024

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

November 8, 2024

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued October 25, 2024

118th CONGRESS

2d Session

H. R. 10038

IN THE HOUSE OF REPRESENTATIVES

October 25, 2024

Mr. D'Esposito (for himself, Mr. Trone, Mr. LaLota, Mr. Lawler, and Mr. Langworthy) introduced the following bill; which was referred to the Committee on Veterans' Affairs

A BILL

To direct the Secretary of Veterans Affairs to conduct a pilot program on the provision of naloxone to veterans and their caregivers, and for other purposes.

Department of Veterans Affairs pilot program on provision of naloxone to veterans and their caregivers

(a)

In general

The Secretary of Veterans Affairs shall carry out a two-year pilot program under which the Secretary shall make naloxone available at pharmacies and medical facilities of the Department to any veteran or registered caregiver of a veteran at no charge and without a prescription.

(b)

Provision of information

The Secretary shall ensure that any veteran or registered caregiver who receives naloxone under the pilot program also receives—

(1)

information about addiction services, suicide prevention services, mental health services, and other related services provided by the Department of Veterans Affairs; and

(2)

information about available resources for education on the use and application of naloxone.

(c)

Report

Not later than 90 days after the completion of the pilot program under this section, the Secretary shall submit to Congress a report on the pilot program. Such report shall include each of the following:

(1)

The number of veterans and registered caregivers who received naloxone under the pilot program.

(2)

An assessment of the feasibility of expanding the pilot program in order to provide naloxone to immediate family members of veterans.

(3)

An assessment of the feasibility or expanding the pilot program to include non-Department medical providers through which the Secretary furnishes hospital care, medical services, and extended care services to veterans under section 1703 of title 38, United States Code.

(4)

An assessment of the effect of a requirement for a consultation by an appropriate medical provider of the Department when providing naloxone to any veteran or registered caregiver for a second time, including whether such a consultation requirement would be likely to reduce the number of veterans and registered caregivers who request naloxone for a second time.

(5)

Any budgetary considerations associated with continuing, expanding, or making permanent the pilot program.

(6)

Any other recommendations of the Secretary with respect to modifying or continuing the pilot program.